Testing for Neuroendocrine Immunohistochemical Markers Should Not Be Performed in Poorly Differentiated NSCCs in the Absence of Neuroendocrine Morphologic Features according to the 2015 WHO Classification. uri icon

Overview

publication date

  • February 1, 2016

Research

keywords

  • Lung Neoplasms
  • World Health Organization

Identity

Scopus Document Identifier

  • 84958982117

Digital Object Identifier (DOI)

  • 10.1016/j.jtho.2015.10.018

PubMed ID

  • 26811228

Additional Document Info

volume

  • 11

issue

  • 2